Facebook post notes Wegovy's accelerated FDA approval for MASH liver fibrosis
The approval covers MASH with F2 to F3 fibrosis, with semaglutide used alongside diet and exercise. A recap of an earlier decision rather than fresh news.
Recap by typeshit. Post by Facebook on Facebook.